Pacer Advisors, Inc. Chemo Centryx, Inc. Transaction History

Pacer Advisors, Inc.

$40.5 Billion
Q4 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 21, 2021	SELL	$9.59 - $50.88 $12,956 - $68,738	-1,351 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$49.53 - $68.4 $44,973 - $62,107	-908 Reduced 40.19%	1,351 $69,000
Q4 2020 Jan 20, 2021	BUY	$47.25 - $65.16 $30,429 - $41,963	644 Added 39.88%	2,259 $140,000
Q3 2020 Oct 19, 2020	BUY	$46.35 - $61.69 $74,855 - $99,629	1,615 New	1,615 $89,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.